Categories No categories LIONESS Medtech at ESTRO Copenhagen May 6-9 2022 4 May 2022 Welcome to visit LIONESS at ESTRO Copenhagen May 6-9, 2022 You will find us in booth 590, at Bella Center. Latest posts LIONESS Medtech at ESTRO Copenhagen May 6-9 2022 4 May 2022 Baptist Health South Florida to Acquire a Second ViewRay MRIdian® MR-Guided Radiation Therapy System 24 October 2021 GenesisCare Expands their MR-guided Radiotherapy Reach with the Purchase of Multiple MRIdian® Systems 27 June 2021 American Hospital in Istanbul, Turkey Purchases MRIdian® MRI-Guided Radiation Therapy System May 25, 2021 26 May 2021 Penn State Health Purchases Second ViewRay MRIdian® Linac February 11, 2021 11 February 2021 Archive 2022LIONESS Medtech at ESTRO Copenhagen May 6-9 20222021Baptist Health South Florida to Acquire a Second ViewRay MRIdian® MR-Guided Radiation Therapy SystemGenesisCare Expands their MR-guided Radiotherapy Reach with the Purchase of Multiple MRIdian® SystemsAmerican Hospital in Istanbul, Turkey Purchases MRIdian® MRI-Guided Radiation Therapy System May 25, 2021Penn State Health Purchases Second ViewRay MRIdian® Linac February 11, 20212020Leading Academic Clinical Training Hospital, Universitair Ziekenhuis Brussels, Purchases ViewRay’s MRIdian LinacPancreatic Cancer in 2020: Surgery and Radiotherapy at the Cutting Edge10,000th Patient Receives Treatment with ViewRay’s MRIdian SystemViewRay, the GenesisCare Foundation and the Pancreatic Cancer Research Fund Work Together to Provide MRIdian Radiation Therapy at No Cost to NHS Pancreatic Cancer PatientsMRI-Linac Consortium to Use RSSearch Patient Registry to Collect and Track MRI-Guided Radiotherapy Treatment Delivery and OutcomesKaohsiung Medical University Chung-Ho Memorial Hospital Begins Patient Treatments with ViewRay’s MRIdian Linac2019First MRIdian MRI-Guided Radiotherapy Treatments Begin in the United Kingdom GenesisCare Oxford Brings the Benefits of Continuous Soft-Tissue Imaging and Adaptive Treatment Delivery to UK Cancer PatientsEuropean Symposium to Advance Adoption of MRI-Guided Radiation TherapyViewRay Announces Results of the First Prospective Clinical Trial on MR-guided Radiation Treatment for Prostate Cancer Without Implanted MarkersWorld’s First MRIdian Center Treats 1,000th Patient with MRI-Guided Radiation TherapyViewRay at ESTRO38 Milan, Italy (MiCo -Milano Convention Centre)ViewRay Announces Publication of Retrospective Study on MR-guided Radiation Treatment for Locally Advanced Pancreatic CancerViewRay Announces FDA 510(k) Clearance for Advancements in MRI and Functional Imaging Technologies for MRIdian MRI-Guided Radiation Therapy SystemWorld’s First MRIdian Center Celebrates Five Years of MRI-Guided Radiation TreatmentsViewRay Announces First Patient Enrolled in Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) Trial for Locally Advanced Pancreatic Cancer2018ASTRO 2018 Presentations to Feature Unique Capabilities and Clinical Outcomes of ViewRay’s MRIdian Next Generation Cancer CareMRI-Guided Radiation Therapy Aims to Prolong Survival and Reduce Complications for the Most Challenging CancersWorld-Leading Oncologists to Meet in Miami for Adaptive MR Image-Guided Radiotherapy SymposiumVU University Medical Center in Amsterdam Delivers First Ever Linear Accelerator-Based On-Table Adaptive MR Image-Guided Radiotherapy Treatment on ViewRay MRIdian® LinacViewRay Unveils New Soft Tissue Visualization Technologies to Further Advance MR Image-Guided RadiotherapyUniversity Clinic Heidelberg Completes Installation and Commissioning of ViewRay’s MRIdian MR ImageGuided Radiotherapy LinacViewRay Surpasses 50th Order for MRIdian® System for Precision Cancer TreatmentViewRay’s MRIdian MR Image-Guided Radiotherapy Linac Receives Japanese Regulatory Approval (Shonin)ViewRay Finalizes Order for MR Image-Guided Radiation Therapy System at University Hospital ZurichLearn about MR-Linac at Radiotherapy Days in Tampere, Finland March 22-23Advanced Applications of MR-Guided Radiotherapy SymposiumAdvanced Applications of MR-Guided Radiotherapy Symposium by ViewRay Inc.2017Oncology Experts to Convene for Symposium to Advance MR Image-Guided Radiation TherapyWashington University Completes Installation of Second MRIdian MR-Guided Radiotherapy System from ViewRayViewRay’s MRIdian Linac Selected as MR-Guided Radiotherapy System in Danish TenderEarly Clinical Data Suggests Nearly 2X Prolonged Median Survival for Inoperable, Locally Advanced Pancreatic Cancer with MRIdian MR-Guided Radiation Therapy Study Indicates Higher Dosing Enabled by MR-guidance Combined with Daily On-table Adaptation Led to Significant Potential Clinical Benefits for Pancreatic Cancer PatientsViewRay Launches Clinical Trial Following Compelling Early Pancreatic Cancer Data with MRIdian System First Initiative Based on Retrospective Study That Suggests Potential for Significantly Prolonged SurvivalViewRay MRIdian to be Featured in 21 Presentations from Seven Leading Centers at ASTROViewRay® to Host Analyst & Investor Meeting at ASTRO in San DiegoVIEWRAY EVENTSEarly Clinical Experience with ViewRay’s MRIdian Linac Presented at Leading Medical Physics Meeting AAPM Talks Highlight Clinical Value of MRIdian On-Table Adaptive Therapy for Escalating Target Dose and Avoiding Nearby Organs at RiskMiami Cancer Institute to Acquire ViewRay’s MRIdian Linac for MRI-Guided Radiation TherapyFirst Patients Treated with ViewRay’s MRIdian Linac System at Henry Ford Health SystemMRIDIAN® STUDY REVEALS NEW BENEFITS FOR BREAST CANCER PATIENTSNational Cancer Center Japan Treats First Patients Using ViewRay MRIdian SystemInstitut du Cancer Montpellier Acquires MRIdian Linac for MRI-Guided RadiotherapyCompelling Early Pancreatic Cancer Data with ViewRay’s MRIdian System Presented at ESTRO 36ViewRay Showcases World’s First Commercially Available MRI-Guided Linac System at Leading European Radiation Oncology MeetingWelcome to ESTRO 36 in ViennaViewRay Receives FDA 510(k) Clearance for MRIdian LinacPrivate Japanese Hospital Purchases ViewRay MRIdian SystemGerman Research Foundation (DFG) Purchases ViewRay MRIdian Linac for University Clinic Heidelberg2016Published Study Highlights MRIdian System’s Value in Sparing Healthy Tissue from RadiationNational Cancer Center Japan Purchases ViewRay MRIdian SystemViewRay Receives CE Mark Approval for its MRIdian Linac SystemViewRay Receives Chinese Regulatory Approval for its MRIdian SystemHenry Ford to Acquire ViewRay MRIdian Linac Research SystemViewRay’s MRIdian System Receives Japanese Regulatory Approval (Shonin)First MRIdian System Installed in Europe at VU University Medical Center of AmsterdamWashington University Acquires ViewRay Research System to Investigate MRI-Guided Linac CapabilitiesWorld’s First MRIdian Center Celebrates Two Years of MRI-Guided Radiation Treatments
